Cellcolabs vs Triomics
Cellcolabs vs Triomics, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cellcolabs is on 55/100 and Triomics on 53/100.
Where each one leads
Cellcolabs
- agent readiness: 40/100 against 30/100
Triomics
- domain rating: 46/100 against 36/100
- funding raised: $22.0M against $15.5M
- LinkedIn following: 131,499 against 6,563
At a glance
| Measure | Cellcolabs | Triomics |
|---|---|---|
| What it is | AI-powered platform for personalized cell therapy development and manufacturing. | Advance every cancer decision. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotech, HealthTech, Drug Discovery, AI-Driven Protein Design |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2021 | 2021 |
| Headquarters | Tel Aviv, Israel | Cambridge, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Cellcolabs | Triomics |
|---|---|---|
| Employees | 79 | 67 |
| Total funding | $15.5M | $22.0M |
| Latest round | Not published | Series B |
| LinkedIn followers | 6,563 | 131,499 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Cellcolabs | Triomics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 55/100 | 53/100 |
| Traction | Not published | 55/100 |
| Search visibility | 2/100 | 33/100 |
| Quality | Not published | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | F (30/100) |
| Domain ratingLink authority, 0-100 | 36/100 | 46/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Cellcolabs | Triomics |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | Not detected | Webflow |
| Analytics | Google Tag Manager | Not detected |
Cellcolabs vs Triomics: common questions
Which is better, Cellcolabs or Triomics?
On our 0-100 score Cellcolabs rates higher (55/100 against 53/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Cellcolabs and Triomics compare on the numbers?
Cellcolabs leads on agent readiness (40/100 against 30/100). Triomics leads on domain rating (46/100 against 36/100), funding raised ($22.0M against $15.5M), LinkedIn following (131,499 against 6,563).
Read the full Cellcolabs review and pricing or the Triomics review and pricing. You can also browse other Cellcolabs alternatives we track.